Bangladesh - inglês - DGDA (Directorate General of Drug Administration)

pharmacil ltd. - sulindac - tablet - 100 mg

Malta - inglês - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - sulindac - tablet - sulindac 200 mg - antiinflammatory and antirheumatic products

África do Sul - inglês - South African Health Products Regulatory Authority (SAHPRA)

adcock -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - sulindac -

Estados Unidos - inglês - NLM (National Library of Medicine)

major pharmaceuticals - sulindac (unii: 184sns8vuh) (sulindac - unii:184sns8vuh) - carefully consider the potential benefits and risks of sulindac tablets and other treatment options before deciding to use sulindac tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). sulindac tablets are indicated for acute or long-term use in the relief of signs and symptoms of the following: sulindac tablets are contraindicated in patients with known hypersensitivity to sulindac or the excipients (see description ). sulindac tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic/anaphylactoid reactions to nsaids have been reported in such patients (see warnings – anaphylactic/anaphylactoid reactions , and precautions – preexisting asthma ).

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ciclosporin 100 mg/ml;   - oral solution - 100 mg/ml - active: ciclosporin 100 mg/ml   excipient: corn oil dl-alpha tocopherol ethanol polyethylene glycol hydrogenated castor oil propylene glycol - transplantation indications solid organ transplantation prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allogeneic transplantations. treatment of transplant rejection in patients previously receiving other immunosuppressive agents. bone marrow transplantation prevention of graft rejection following bone marrow transplantation. prevention or treatment of graft-versus-host disease (gvhd).

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ciclosporin 100mg;   - soft gelatin capsule - 100 mg - active: ciclosporin 100mg   excipient: corn oil dl-alpha tocopherol ethanol gelatin glycerol iron oxide black polyethylene glycol hydrogenated castor oil propylene glycol   titanium dioxide - solid organ transplantation prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allogeneic transplantations. treatment of transplant rejection in patients previously receiving other immunosuppressive agents. bone marrow transplantation prevention of graft rejection following bone marrow transplantation. prevention or treatment of graft-versus-host disease (gvhd).

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

abbvie limited - ritonavir 100mg - film coated tablet - 100 mg - active: ritonavir 100mg excipient: calcium hydrogen phosphate colloidal silicon dioxide copovidone opadry white 16b18449 sodium stearyl fumarate sorbitan laurate - norvir is indicated for use in combination with appropriate antiretroviral agents or as monotherapy if combination therapy is inappropriate, for the treatment of hiv-1 infection in adults and children aged 12 years and older. for persons with advanced hiv disease, the indication for ritonavir is based on the results for one study that showed a reduction in both mortality and aids defining clinical events for patients who received ritonavir. median duration of follow-up in this study was 6 months. the clinical benefit from ritonavir for longer periods of treatment is unknown. for persons with less advanced disease, the indication is based on changes in surrogate markers in controlled trials of up to 16 weeks duration.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - ciclosporin 100mg - soft gelatin capsule - 100 mg - active: ciclosporin 100mg excipient: ethyl lactate gelatin glycerol iron oxide black lecithin medium-chain triglycerides peg-40 castor oil polysorbate 20 purified water sorbitan oleate titanium dioxide - solid organ transplantation: - prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allergenic transplantations. - treatment of transplant rejection in patients previously receiving other immunosuppressive agents.

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - sulindac - oral tablet - 200mg